English   español  

Browsing by Author Garayoa, Mercedes

Showing results 1 to 15 of 15
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2008Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivoMitsiades, C. S.; Ocio, Enrique M.; Pandiella, Atanasio; Maiso, Patricia; Gajate, Consuelo; Garayoa, Mercedes; Vilanova, David; Montero, Juan Carlos; Mollinedo, Faustino; San Miguel, Jesús F.Artículo
openAccessCD20 positive.pdf.jpg2012CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype.Paíno, Teresa; Ocio, Enrique M.; Paiva, Bruno; San-Segundo, Laura; Garayoa, Mercedes; Gutiérrez, Norma Carmen; Sarasquete, María Eugenia; Pandiella, Atanasio; Orfao, Alberto; San Miguel, Jesús F.Artículo
openAccessDasatinib as.pdf.jpg2012Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effectsGarcia-Gomez, Antonio; Ocio, Enrique M.; Crusoe, Edvan; Santamaría, Carlos; Hernández-Campo, Pilar M.; Blanco, Juan F.; Sánchez-Guijo, Fermín M.; Hernández, M. Teresa; Briñón, Jesús G.; Pandiella, Atanasio; San Miguel, Jesús F.; Garayoa, MercedesArtículo
openAccess10.3324-haematol.2009.015495.pdf.jpg1-May-2010In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myelomaOcio, Enrique M.; Vilanova, David; Maiso, Patricia; Crusoe, Edvan; Fernández-Lázaro, Diego; Garayoa, Mercedes; San-Segundo, Laura; Hernández, M. Teresa; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2009Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donorsGenomic profile of multiple myeloma MSCsGarayoa, Mercedes; García, Juan L.; Santamaría, Carlos; Garcia-Gomez, Antonio; Blanco, Juan F.; Pandiella, Atanasio; Hernández, Jesús M.; Sánchez-Guijo, Fermín M.; Cañizo, María Consuelo del; Gutiérrez, Norma Carmen; San Miguel, Jesús F.Artículo
openAccessMultipleMyelomaCellLines.PDF.jpg2014Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell linesPaíno, Teresa; Sarasquete, María Eugenia; Paiva, Bruno; Krzemiński, Patryk; San-Segundo, Laura; Corchete, Luis A.; Redondo, Alba; Garayoa, Mercedes; García-Sanz, Ramón; Gutiérrez, Norma Carmen; Ocio, Enrique M.; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2014Preclinical activity of the oral proteasome inhibitor mln9708 in myeloma bone diseaseGarcia-Gomez, Antonio; Ocio, Enrique M.; Blanco, Juan F.; Hernández-Iglesias, Teresa; Fraile, Susana ; San Miguel, Jesús F.; Garayoa, MercedesArtículo
closedAccessaccesoRestringido.pdf.jpg2013RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implicationsGarcia-Gomez, Antonio; Ocio, Enrique M.; Pandiella, Atanasio; San Miguel, Jesús F.; Garayoa, MercedesArtículo
openAccessGarcia Bernal et al.pdf.jpgFeb-2013Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin functionGarcía-Bernal, David; Redondo-Muñoz, Javier; Dios-Esponera, Ana; Chèvre, Raphaël; Bailón, Elvira; Garayoa, Mercedes; Arellano-Sánchez, Nohemí; Gutiérrez, Norma C.; Hidalgo, Andrés; García-Pardo, Angeles; Teixidó, JoaquínArtículo
openAccessThe effect of the proteasome.pdf.jpg2008The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotypeColado, Enrique; Álvarez-Fernández, Stela; Maiso, Patricia; Martín, Jesús; Vidriales, Belén; Garayoa, Mercedes; Ocio, Enrique M.; Montero, Juan Carlos; Pandiella, Atanasio; San Miguel, Jesús F.Artículo
openAccessepoxyketone-based.pdf.jpg2013The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effectsGarcia-Gomez, Antonio; Ocio, Enrique M.; Blanco, Juan F.; Pandiella, Atanasio; San Miguel, Jesús F.; Garayoa, Mercedes; Weilbaecher, K. N.Artículo
closedAccessaccesoRestringido.pdf.jpg2008The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cellsMaiso, Patricia; Ocio, Enrique M.; Garayoa, Mercedes; Montero, Juan Carlos; Pandiella, Atanasio; San Miguel, Jesús F.Artículo
closedAccessaccesoRestringido.pdf.jpg2009The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repairSynergy of panobinostat and doxorubicin in AMLMaiso, Patricia; Colado, Enrique; Ocio, Enrique M.; Garayoa, Mercedes; Pandiella, Atanasio; San Miguel, Jesús F.Artículo
openAccessmyelomabonedisease.pdf.jpg2014Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone diseaseGarcia-Gomez, Antonio; De Las Rivas, Javier; Ocio, Enrique M.; Díaz-Rodríguez, Elena; Montero, Juan Carlos; Martín, Montserrat; Blanco, Juan F.; Sánchez-Guijo, Fermín M.; Pandiella, Atanasio; San Miguel, Jesús F.; Garayoa, MercedesArtículo
closedAccessaccesoRestringido.pdf.jpg2012Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myelomaQueiroz Crusoe, Edvan de; Maiso, Patricia; Fernández-Lázaro, Diego; San-Segundo, Laura; Garayoa, Mercedes; Garcia-Gomez, Antonio; Gutiérrez, Norma Carmen; Delgado, Manuel; Colado, Enrique; Ocio, Enrique M.Artículo